News

Optical coherence tomography is beneficial for measuring visual changes and the impact of comorbidities in MS, NMOSD, and ...
Discover how the brain "eats" itself during a marathon, and how the recovery process opens doors to possible MS treatments.
The FDA’s regular communications based on reports from its drug safety report database don’t always rattle investors’ cages.
A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...
The safety update for Vyvgart rattled argenx’s shares on Monday, a reaction that analysts at William Blair said was “overdone ...
A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for ...
Multiple sclerosis (MS) is an immune-mediated inflammatory disease characterized by demyelination and degeneration in the ...
UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...
A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...
A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...
FDA raised safety concerns for Vyvgart Hytrulo in CIDP, while Argenx moves ARGX-119 into late-stage trials for rare ...
Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, per a study.